Sibeprenlimab in IgA Nephropathy — Interim Analysis of a Phase 3 Trial
Original Article
V. Perkovic, H. Trimarchi, V. Tesar, R. Lafayette, M.G. Wong, J. Barratt, Y. Suzuki, A. Liew, H. Zhang, K. Carroll, V. Jha, A. Quevedo, S.H. Han, M. Praga, B. Chacko, M. Sahay, C.K. Cheung, L. Kooienga, M. Walsh, J. Xia, C. Fajardo, L. Shah, J. Hafkin, and D.V. Rizk
N Engl J Med 2026;394:635-646
Available Credit
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Please sign in or create an account to take the course.

Facebook
X
LinkedIn
Forward